If budesonide-formoterol were to become available over the counter (OTC) and used as-needed for mild asthma, it would save lives and cut healthcare costs, according to a computer modeling study ...

The management of asthma has changed since the introduction of budesonide/formoterol (Symbicort ®) as both maintenance and reliever therapy (SMART). SMART and its effects on bronchial ...

Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...

AstraZeneca today announced that the United States District Court for the District of New Jersey ruled that AstraZeneca's US Patent No. 6,598,603 ("the '603 patent"), protecting PULMICORT RESPULES in ...

Please provide your email address to receive an email when new articles are posted on . Short-term budesonide transnasal nebulization effectively and safely treated patients with chronic ...

Budesonide (micronized) 0.25mg/2mL, 0.5mg/2mL, 1mg/2mL; susp for inhalation. Pulmicort Respules is supplied in sealed aluminum foil envelopes containing one plastic strip of five single-dose Respules ...

NEW YORK (Reuters) - AstraZeneca Plc and Teva Pharmaceutical Industries Ltd said on Tuesday they have reached a settlement in their patent infringement dispute over AstraZeneca's Pulmicort Respules ...

The United States District Court for the District of New Jersey has ruled that AstraZeneca’s patent No. 6,598,603, which was protecting Pulmicort Respules in the United States, is invalid. Pulmicort ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Budesonide (Pulmicort) is a corticosteroid, ...

Pulmicort (budesonide) is an asthma drug that’s considered safe to use while pregnant. The drug passes into breast milk but is also considered safe to use while breastfeeding. Pulmicort is generally ...

AstraZeneca today announced that the US District Court for the District of New Jersey ruled US Patent No. 7,524,834 ("the '834 patent"), protecting PULMICORT RESPULES in the US, is invalid.

Budesonide (Pulmicort (200 mcg)) is a corticosteroid, prescribed for inflammatory bowel disease, asthma, and also for breathing trouble. Budesonide is indicated for: 1. Treatment of Mild to Moderate ...